Netarsudil: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Netarsudil. Educational only — not medical advice.
Labeled uses
ROCKLATAN is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Source: FDA labeling via NIH DailyMed (set b1d71f41…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.